Two Sigma Advisers’s LAVA Therapeutics LVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-26,900
Closed -$44.7K 2446
2024
Q3
$44.7K Sell
26,900
-4,800
-15% -$7.97K ﹤0.01% 2220
2024
Q2
$57.1K Buy
31,700
+15,000
+90% +$27K ﹤0.01% 2354
2024
Q1
$55.6K Buy
+16,700
New +$55.6K ﹤0.01% 2345